Cardiovascular Clinical Trials

Cardiovascular disease remains the leading cause of death worldwide, often developing silently through the buildup of plaque inside the arteries – a condition known as atherosclerosis. Hightower Clinical is conducting a cardiovascular prevention clinical trial aimed at identifying and reducing the risk of heart attacks and strokes in individuals who are at higher cardiovascular risk.

Participation in this study is voluntary, free of charge, and open to adults aged 55 and older who have conditions such as diabetes, prediabetes, or metabolic syndrome but no known symptoms of heart disease.

Participants will be randomly assigned to a Control group (receiving standard preventive care) or an Experimental group (receiving an imaging-based, personalized prevention plan). Throughout the study, participants will receive advanced imaging assessments, regular health evaluations, and expert care from experienced cardiovascular specialists.

Hypertension, or high blood pressure, is a common yet serious condition that increases the risk of heart disease, stroke, and kidney damage. Hightower Clinical is conducting a hypertension clinical trial in Oklahoma City to study an investigational, pacemaker-based treatment designed to help regulate blood pressure in individuals with essential or systolic hypertension.

Participation in this clinical study is voluntary, completely free of charge, and open to adults aged 18 and older who either have or are receiving a dual-chamber pacemaker.

Participants will be randomly assigned to a Control group (receiving standard pacemaker settings) or an Experimental group (receiving investigational pacing therapy). Throughout the study, you’ll receive expert care and close monitoring from experienced cardiovascular physicians as we work together to advance the future of hypertension treatment.

Peripheral vascular disease (PVD) can lead to serious complications such as pain, reduced mobility, and an increased risk of cardiovascular issues. Hightower Clinical is conducting a clinical trial in Oklahoma City to evaluate an investigational treatment aimed at improving blood flow and managing PVD symptoms. Participation is voluntary, free of charge, and open to individuals aged 18 and older.

Participants will be randomly assigned to a Control group (receiving a placebo) or an Experimental group (receiving the investigational treatment). Throughout the study, you’ll receive expert care from experienced physicians as we work toward advancing treatment options.

Explore the Librexia Stroke clinical trials in Oklahoma City, OK, where you can help advance research for effective stroke management. Stroke remains a leading cause of mortality and disability, highlighting the urgent need for improved treatments. Hightower Clinical is conducting a Phase 3 study to evaluate an investigational drug’s safety and efficacy for stroke survivors. Participation is free of cost and voluntary, with comprehensive care provided by expert physicians. Don’t miss your chance to make a difference—fill out the form to learn more about your eligibility today!

Heart failure is a chronic condition affecting millions in the U.S., often leading to impaired kidney function. Hightower Clinical is conducting clinical trials in Oklahoma City to explore innovative treatments for heart failure and its impact on kidney health. By joining the trial, you can contribute to advancing treatment options and potentially improve your own quality of life. If you’re struggling with heart failure, this is your chance to help shape future therapies. All study-related procedures will be provided free of charge.

Severe hypertriglyceridemia can lead to serious health issues like pancreatitis and cardiovascular disease. Hightower Clinical is conducting clinical trials in Oklahoma City to test an investigational drug aimed at reducing triglyceride levels. Participation is voluntary, free, and open to individuals aged 22 and older. The trial involves being randomly placed into either a Control group (receiving a placebo) or an Experimental group (receiving the drug). With thorough care from experienced physicians, this study aims to find better treatments. Enroll today to see if you qualify and contribute to improving health outcomes.